| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:SARS-CoV-2 nsp13-IN-3
CAS:1015582-31-6
Package:100mg/RMB 17500;25mg/RMB 10600;50mg/RMB 13800
|
7-[4-(4,6-dimethylpyrimidin-2-yl)piperazin-1-yl]-2-(2-methoxyphenyl)-5-methylpyrazolo[1,5-a]pyrimidine manufacturers
- SARS-CoV-2 nsp13-IN-3
-
- $2500.00 / 100mg
-
2025-07-31
- CAS:1015582-31-6
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | 7-[4-(4,6-dimethylpyrimidin-2-yl)piperazin-1-yl]-2-(2-methoxyphenyl)-5-methylpyrazolo[1,5-a]pyrimidine Basic information |
| | 7-[4-(4,6-dimethylpyrimidin-2-yl)piperazin-1-yl]-2-(2-methoxyphenyl)-5-methylpyrazolo[1,5-a]pyrimidine Chemical Properties |
| density | 1.30±0.1 g/cm3(Predicted) | | pka | 6.39±0.50(Predicted) |
| | 7-[4-(4,6-dimethylpyrimidin-2-yl)piperazin-1-yl]-2-(2-methoxyphenyl)-5-methylpyrazolo[1,5-a]pyrimidine Usage And Synthesis |
| Uses | SARS-CoV-2 nsp13-IN-3 (Compound C3) is a SARS-CoV-2 non-structural protein 13 (nsp13) small-molecule inhibitor with an IC50 of 32 μM against nsp13 ssDNA+ ATPase[1]. | | References | [1] Yazdi AK, et al. Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors. ACS Infect Dis. 2022 Jul 13. DOI:10.1021/acsinfecdis.2c00165 |
| | 7-[4-(4,6-dimethylpyrimidin-2-yl)piperazin-1-yl]-2-(2-methoxyphenyl)-5-methylpyrazolo[1,5-a]pyrimidine Preparation Products And Raw materials |
|